Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Joe is not a stupid man....he is a good business m

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36568
(Total Views: 542)
Posted On: 03/23/2019 4:53:04 AM
Posted By: Msowid
Re: Bob g #2917
Joe is not a stupid man....he is a good business man with a good acumen for deals.....when the Olaregen opportunity presented itself and thorough due diligence was done, he saw the need to bring on the executive team along with it as well......when these guys bought the rights of Exellagen, they were not doing it for cheap....they had a gem and they knew it.....
(West Africans were sitting on gold and diamond mines for 100's of years and did not take advantage of it until the colonialists came and dug it out from the grounds, using the native people to haul it out for them)...i digress...

That Joe agreed to amend the salary scale while in the middle of the acquisition process is very interesting.....from the tid bits of info that we got from the conference call on Feb. 26....and i quote, Dolisi and Purcell....
"The completion of our comprehensive sales training modules, and with the
hiring of a number of experienced specialty sales reps, we are poised to enter
the market with our 0.8 cc syringe, selling it to the VA inpatient and wound
care clinics, the DOD, and in-hospital surgical settings. With the supporting
data on Excellagen features and benefits, together with our value-based
pricing, we anticipate early uptake in these markets."....

to me this says a lot when you have the department of defense, the VA clinics and hospital wards geared to receiving this product....these will be major contracts signed to receive hundreds of thousands of dollars for said product...

These executives staying on is a positive sign and should be viewed as such.....and to get them to stay on, you have to pay them their worth (even though not proven yet)......for finding the gem.....


(1)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us